New HHS Board Will Hear 340B Drug Pricing Disputes
By EsqSocial Corporation 16/12/20
On December 14, 2020, HRSA established a long overdue Administrative Dispute Resolution (ADR) process that allows covered entities and drug manufacturers to bring claims against each other related to the 340B Drug Pricing Program (340B Program). The ADR process will allow covered entities and drug manufacturers to formally request agency review of alleged 340B violations....
By: Foley & Lardner LLP